Contact

Perception Neuroscience Holdings, Inc.
230 Riverside Dr. 19D, New York, NY 10025
United States of America

Contact us via email: info@perceptionneuroscience.com

Home | Careers | Contact

ATAI is looking into different ways to increase the human healthspan and reverse aging

Technological advances in areas like genomics, stem cell therapy, immunology and nanotechnology will change how we age.

We believe that

Christian Angermayer

Founder

Strategy and investor relations

Lars Wilde

Co-founder

Drug discovery and compound sourcing

Florian Brand

Co-founder and CEO

Drug development and operations

Simon Seibold

Associate

Investments and business development

Philipp Schreiber

Associate

Drug discovery and compound sourcing

ATAI is supporting the revival of psychedelic compounds, such as psilocybin and ketamine, in the treatment of mental health conditions

Depression, anxiety, post-traumatic stress disorder, obsessive-compulsive disorder, bipolar disorder and other psychiatric conditions are increasingly becoming a burden for patients, families and societies.

We believe that

ATAI is leveraging the potential of artificial intelligence (AI) and big data analytics to optimize and accelerate the drug development process

Technological innovation will enable us to consolidate and make sense of vast amounts of previously inaccessible data.

We believe that

Sorry,

there are no positions available at this time.

Please check back soon.